This inventor holds 3 USPTO granted patents. Top assignee: Smithkline Beecham Corporation. Active years: 1998-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2002
Title: Innovator Spotlight: Chantal Myriam Petit
Introduction: Chantal Myriam Petit is a notable inventor based in Wayne, Pennsylvania, whose contributions to the field of biotechnology have led to significant advancements in antibacterial research. With three patents to her name, Petit has proven herself as a leading figure in her field, demonstrating her dedication to innovation and research.
Latest Patents: Among her recent inventions, Petit has developed novel polypeptides and polynucleotides aimed at combating bacterial infections. Her latest patents include:
1. **PgsA** - This invention encompasses pgsA polypeptides and the methodologies for producing these polypeptides through recombinant techniques. Additionally, this patent outlines approaches for utilizing pgsA polypeptides in screening for antibacterial compounds.
2. **PyrH of Streptococcus pneumoniae** - This invention involves pyrH polypeptides and methods for their production via recombinant techniques. Similar to her previous patent, it also provides methods for using pyrH polypeptides to screen for antibacterial compounds.
Career Highlights: Chantal Myriam Petit has built her career at Smithkline Beecham Corporation, where she has engaged in groundbreaking research that bridges her expertise with innovative solutions in medical biotechnology. Her work is crucial in the ongoing fight against antibiotic resistance and has opened new avenues for therapeutic development.
Collaborations: Throughout her career, Petit has collaborated with esteemed colleagues such as David John Holmes and Christopher Michael Traini. These partnerships have enhanced her capacity for innovation and have contributed to a collaborative research environment focused on significant advancements in healthcare.
Conclusion: Chantal Myriam Petit exemplifies the spirit of innovation that drives the biotechnology sector forward. With her valuable patents and ongoing contributions, she plays a critical role in the development of new antibacterial strategies, proving that dedication to research and collaboration can lead to meaningful advances in health science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile